Overcoming negative predictions of microRNA expressions to gemcitabine response with FOLFIRINOX in advanced pancreatic cancer patients

FOLFIRINOX is superior to gemcitabine in patients with pancreatic cancer, but this regimen is associated with toxicity and biomarkers for response are warranted. MicroRNAs can mediate drug resistance and could provide predictive information. Altered expressions of several microRNAs including miR-21-...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Future Sci OA
Main Authors: Schlick, Konstantin, Hohla, Florian, Hamacher, Frank, Hackl, Hubert, Hufnagl, Clemens, Markus, Steiner, Magnes, Teresa, Gampenrieder, Simon Peter, Melchardt, Thomas, Stättner, Stefan, Hauser-Kronberger, Cornelia, Greil, Richard, Rinnerthaler, Gabriel
פורמט: Artigo
שפה:Inglês
יצא לאור: Future Science Ltd 2020
נושאים:
Research Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7787156/
https://ncbi.nlm.nih.gov/pubmed/33437513
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2144/fsoa-2020-0128
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים